Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Liabilities (2018 - 2025)

AVITA Medical filings provide 8 years of Total Liabilities readings, the most recent being $73.0 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 2.57% to $73.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $73.0 million, a 2.57% decrease, with the full-year FY2025 number at $73.0 million, down 2.57% from a year prior.
  • Total Liabilities hit $73.0 million in Q4 2025 for AVITA Medical, up from $70.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $75.0 million in Q4 2024 to a low of $8.7 million in Q1 2022.
  • Median Total Liabilities over the past 5 years was $16.9 million (2023), compared with a mean of $37.6 million.
  • Biggest five-year swings in Total Liabilities: dropped 5.12% in 2022 and later surged 377.3% in 2023.
  • AVITA Medical's Total Liabilities stood at $11.4 million in 2021, then grew by 13.84% to $13.0 million in 2022, then surged by 377.3% to $61.9 million in 2023, then rose by 21.13% to $75.0 million in 2024, then fell by 2.57% to $73.0 million in 2025.
  • The last three reported values for Total Liabilities were $73.0 million (Q4 2025), $70.4 million (Q3 2025), and $71.0 million (Q2 2025) per Business Quant data.